A recent study by Esteghamat et al., published in Nature Genetics, has reported that CELA2A, encoding a pancreatic enzyme, is a novel genetic cause of metabolic syndrome and atherosclerosis.
References
Kahn, R., Buse, J., Ferrannini, E. & Stern, M. Diabetes Care 28, 2289–2304 (2005).
Nelson, M. R. et al. Nat. Genet. 47, 856–860 (2015).
Gloyn, A. L. et al. N. Engl. J. Med. 350, 1838–1849 (2004).
Montague, C. T. et al. Nature 387, 903–908 (1997).
Esteghamat, F. et al. Nat. Genet. https://doi.org/10.1038/s41588-019-0470-3 (2019).
Logsdon, C. D. & Ji, B. Nat. Rev. Gastroenterol. Hepatol. 10, 362–370 (2013).
Beck, I. T. Am. J. Clin. Nutr. 26, 311–325 (1973).
Kayani, K., Mohammed, R. & Mohiaddin, H. Front. Endocrinol. (Lausanne) 9, 20 (2018).
Moran, A. et al. Diabetes Care 32, 1626–1631 (2009).
’t Hart, L. M. et al. Diabetes 62, 3275–3281 (2013).
Acknowledgements
A.L.G. is a Wellcome Senior Fellow in Basic Biomedical Science (095101/Z/10/Z and 200837/Z/16/Z). A.L.G. is also supported by the Oxford NIHR Biomedical Research Centre. The views expressed in this article are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
Gloyn, A.L. Exocrine or endocrine? A circulating pancreatic elastase that regulates glucose homeostasis. Nat Metab 1, 853–855 (2019). https://doi.org/10.1038/s42255-019-0107-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s42255-019-0107-y
- Springer Nature Limited